Saxenda is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Liraglutide.
Product ID | 0169-2800_22354b1e-31ba-4cad-974e-3620604d2f6d |
NDC | 0169-2800 |
Product Type | Human Prescription Drug |
Proprietary Name | Saxenda |
Generic Name | Liraglutide |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2014-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA206321 |
Labeler Name | Novo Nordisk |
Substance Name | LIRAGLUTIDE |
Active Ingredient Strength | 6 mg/mL |
Pharm Classes | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2015-01-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206321 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-01-19 |
Marketing Category | NDA |
Application Number | NDA206321 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-01-19 |
Marketing Category | NDA |
Application Number | NDA206321 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-01-19 |
Ingredient | Strength |
---|---|
LIRAGLUTIDE | 6 mg/mL |
SPL SET ID: | 3946d389-0926-4f77-a708-0acb8153b143 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0169-2800 | Saxenda | liraglutide |
50090-4257 | Saxenda | liraglutide |
0169-4060 | Victoza | liraglutide |
50090-2853 | Victoza | liraglutide |
50090-4503 | Victoza | liraglutide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SAXENDA 79141628 4541356 Live/Registered |
Novo Nordisk A/S 2013-10-25 |